Division of Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charlston, SC, USA.
Prog Cardiovasc Dis. 2013 Jul-Aug;56(1):68-73. doi: 10.1016/j.pcad.2013.04.002. Epub 2013 May 15.
Thoracic aortic aneurysm (TAA) is a clinically silent and potentially fatal disease whose pathophysiology is poorly understood. Application of data derived from animal models and human tissue analysis of abdominal aortic aneurysms may prove misleading given current evidence of structural and biochemical aortic heterogeneity above and below the diaphragm. Genetic predisposition is more common in TAA and includes multi-faceted syndromes such as Marfan, Loeys-Dietz, and type IV Ehlers-Danlos as well as autosomal-dominant familial patterns of inheritance. Investigation into the consequences of these known mutations has provided insight into the cell signaling cascades leading to degenerative remodeling of the aortic medial extracellular matrix (ECM) with TGF-β playing a major role. Targeted research into modifying the upstream regulation or downstream effects of the TGF-β1 pathway may provide opportunities for intervention to attenuate TAA progression.
胸主动脉瘤(TAA)是一种临床上无症状但潜在致命的疾病,其病理生理学尚不清楚。由于目前存在膈肌上下主动脉结构和生化异质性的证据,从动物模型和人类腹主动脉瘤组织分析中得出的数据的应用可能会产生误导。TAA 中更常见遗传易感性,包括马凡氏综合征、Loeys-Dietz 综合征和 IV 型埃勒斯-当洛斯综合征等多方面的综合征,以及常染色体显性家族遗传模式。对这些已知突变的后果的研究提供了对导致主动脉中层细胞外基质(ECM)退行性重塑的细胞信号级联的深入了解,其中 TGF-β 起着重要作用。针对 TGF-β1 途径的上游调节或下游效应进行有针对性的研究,可能为干预减轻 TAA 进展提供机会。